Treating mast cell activation syndrome (MCAS) typically requires a layered approach, starting with antihistamines and building up to mast cell stabilizers, dietary changes, trigger avoidance, and sometimes biologic therapies. There is no single medication that resolves MCAS for everyone. Most people work through a stepwise protocol, adding treatments one at a time until symptoms are manageable.
Antihistamines: The Foundation of Treatment
The first step in nearly every MCAS treatment plan is a combination of two types of antihistamines, H1 and H2, taken together. They target different receptors on the mast cell, and using both provides broader stabilization than either one alone.
H1 antihistamines address itching, flushing, headaches, brain fog, and abdominal pain. Second-generation options like cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra), and levocetirizine (Xyzal) are preferred because they cause less drowsiness. Ketotifen, available over the counter in some countries, pulls double duty as both an H1 blocker and a mild mast cell stabilizer. First-generation options like diphenhydramine (Benadryl) or hydroxyzine work well but tend to cause sedation, so they’re often reserved for nighttime or flare situations.
H2 antihistamines are the same drugs commonly sold for heartburn. Famotidine (Pepcid) is the most widely used. These help with gastrointestinal symptoms specifically but also contribute to overall mast cell stability. Taking an H1 and an H2 antihistamine together is considered necessary rather than optional, because they stabilize different receptor sites on the mast cell.
Dosing is highly individual. Many people with MCAS need higher or more frequent doses than what the package recommends for seasonal allergies, and finding the right combination often takes several adjustments with a specialist.
Mast Cell Stabilizers
If antihistamines alone don’t provide adequate relief, the next layer is a mast cell stabilizer, most commonly cromolyn sodium taken orally. Cromolyn works by preventing mast cells from releasing their inflammatory contents in the first place, rather than blocking the effects after release. It’s particularly effective for GI symptoms like cramping, nausea, and diarrhea.
The standard starting dose is 200 mg four times daily, taken 30 minutes before meals and at bedtime. Because some people are sensitive to new medications, a common clinical approach is to start lower and build up. One protocol begins at 400 mg per day during the first week, increases to 800 mg in week two, then continues climbing in weekly increments of 400 mg if symptoms haven’t improved. Doses of 1,600 to 2,400 mg per day have been well tolerated in patients who didn’t respond at the conventional 800 mg dose. If a higher dose doesn’t add benefit within a week, you drop back to the level where improvement first appeared.
Cromolyn is available in the U.S. as a liquid preparation (100 mg per 5 mL). It’s poorly absorbed, which means it acts locally in the gut and has very few systemic side effects. That’s a real advantage for people who react easily to medications.
Leukotriene Blockers
Mast cells release more than just histamine. They also produce leukotrienes, inflammatory molecules that cause wheezing, airway tightness, and abdominal cramping. Medications like montelukast and zafirlukast block the effects of these leukotrienes, while zileuton blocks their production. These are often added when respiratory symptoms or persistent abdominal cramping don’t respond to antihistamines alone.
Low-Histamine Diet
Dietary changes won’t cure MCAS, but they can significantly reduce the daily histamine load your body has to process. Clinical studies on low-histamine diets consistently report symptom improvement rates above 70%.
The foods most commonly eliminated include fermented products like aged cheese, dry-cured sausages, wine, and beer. Other frequently flagged items are citrus fruits, tomatoes, spinach, strawberries, pineapple, papaya, chocolate, nuts, and seafood. These foods either contain high levels of histamine or are thought to trigger histamine release directly.
The practical approach is an elimination phase lasting two to four weeks, followed by a slow reintroduction of individual foods to identify personal triggers. Not everyone reacts to every item on the list, so the goal is to find your specific pattern rather than permanently avoiding all of them. Some people also take diamine oxidase (DAO) supplements before meals. DAO is the enzyme your body uses to break down histamine from food, and supplementing it can help bridge the gap for people whose natural DAO levels are low.
Identifying and Avoiding Triggers
MCAS triggers extend well beyond food. Common categories include fragrances, temperature changes (both heat and cold), emotional stress, physical stress, exercise, infections, hormonal shifts, pressure on the skin, and certain medications or supplements. Even the inactive ingredients in medications, like dyes or fillers, can provoke reactions in sensitive individuals.
Keeping a symptom journal that logs exposures, activities, and reactions is one of the most effective tools for spotting patterns. Over time, many people learn to anticipate and premedicate before known triggers, like taking extra antihistamines before exercise or before entering environments with strong fragrances.
For indoor environments, HEPA air filtration and dehumidification can reduce airborne mold spores, dust, and other particulate triggers. This matters especially in bedrooms and workspaces where you spend long hours.
Biologic Therapy for Refractory Cases
When the standard layered approach isn’t enough, omalizumab (Xolair) is the most studied biologic option for refractory MCAS. A systematic review from Penn State compiled data on 28 patients who had failed to respond to at least an H1 antihistamine plus one other antimediator agent. After starting omalizumab, 61% of patients achieved a partial response and an additional five patients (about 18%) had a complete response. It was also effective at reducing anaphylaxis episodes and allowed two out of three patients on long-term steroids to stop them.
Complete responses were more common at higher doses (300 mg or more per month). The response didn’t depend on sex or whether the MCAS was clonal or non-clonal, which suggests broad applicability. Omalizumab is given as an injection, typically every two to four weeks, and it can take several months to see the full effect.
Supplements That May Help
Quercetin is the most commonly discussed supplement for MCAS. It’s a plant flavonoid that appears to help stabilize mast cells and reduce histamine release. Typical doses range from 500 to 1,000 mg per day, and liposomal formulations may be better absorbed. It’s not a substitute for medication in moderate to severe MCAS, but some people find it helpful as an add-on.
Vitamin C also supports histamine metabolism and is frequently included in MCAS supplement protocols. As with any supplement, starting low and increasing gradually is wise, since people with MCAS can react to fillers, coatings, or even the active ingredients themselves.
Emergency Preparedness
People with MCAS who have experienced anaphylaxis, or whose specialist considers them at risk for it, should carry epinephrine auto-injectors at all times. Epinephrine is the first-line treatment for anaphylaxis regardless of cause, and early administration improves outcomes. If a first dose doesn’t resolve symptoms, a second dose can be given after five minutes.
Because MCAS-related anaphylaxis can be triggered unpredictably, many specialists recommend carrying two auto-injectors. Having a written anaphylaxis action plan, shared with family members or coworkers, removes the guesswork during an emergency.
Building a Treatment Plan That Works
The layered approach to MCAS treatment looks something like this in practice: you start with H1 and H2 antihistamines, add a mast cell stabilizer like cromolyn if needed, layer in a leukotriene blocker for respiratory or cramping symptoms, adopt dietary modifications, and pursue trigger avoidance. Biologics enter the picture only when these steps aren’t sufficient. Each layer is introduced one at a time so you can isolate what’s helping.
Responses vary enormously from person to person. A medication that transforms one patient’s quality of life may do nothing for another. This is partly because mast cells release over 200 different chemical mediators, and no single drug blocks all of them. The practical consequence is that treatment requires patience and systematic experimentation, ideally with a provider experienced in mast cell disease. Finding the right combination can take months, but most people do eventually reach a regimen that substantially reduces their symptom burden.